Intestinal Absorption Enhancement of the Ester Prodrug Tenofovir Disoproxil Fumarate through Modulation of the Biochemical Barrier by Defined Ester Mixtures
- 1 August 2002
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 30 (8) , 924-930
- https://doi.org/10.1124/dmd.30.8.924
Abstract
The effect of discrete esters and ester mixtures on the intestinal stability and absorption of tenofovir disoproxil fumarate (tenofovir DF, an esterase-sensitive prodrug of the antiviral tenofovir) was compared with the effect of strawberry extract, which has been shown to enhance the absorption of the prodrug across Caco-2 monolayers and in rat ileum. In addition, the mechanism of absorption enhancement was investigated. In rat intestinal homogenates, complete inhibition of the conversion of tenofovir DF (as obtained by strawberry extract) could only be obtained at relatively high concentrations of the discrete esters or by using mixtures of esters (e.g., propylp-hydroxybenzoate 0.02%, octyl acetate 0.02%, ethyl caprylate 0.01%). Coincubation of tenofovir DF with this mixture also resulted in an enhancement of its absorption in the in vitro Caco-2 system as well as in rat ileum. As tenofovir DF is a substrate for P-glycoprotein (P-gp)-related efflux carriers in the Caco-2 model, the modulatory effect of the ester mixtures was studied on the functionality of P-gp using cyclosporin A (CsA) as a model substrate. Strawberry extract as well as the mixture of three esters interfered with the absorptive transport of CsA across Caco-2 monolayers, illustrating that both mixtures interfere with both esterase-activity and P-gp functionality. This concerted barrier was not observed in rat ileum, suggesting differential functional activities of the biochemical barrier toward tenofovir DF in different absorption systems. Overall, our results illustrate that modulation of the biochemical barrier (metabolism and efflux) of tenofovir DF by ester mixtures can be used to increase the intestinal absorption of tenofovir DF in an in vitro and an in situ absorption model; the mechanism of action appears to be a complex interplay of different systems; the differential expression of carriers and enzymes in different systems illustrates the difficulty of extrapolating observations between different systems/species.This publication has 24 references indexed in Scilit:
- In Vitro, Ex Vivo, and In Situ Intestinal Absorption Characteristics of the Antiviral Ester Prodrug Adefovir DipivoxilJournal of Pharmaceutical Sciences, 2000
- Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extractEuropean Journal Of Cancer, 1999
- Safety, Pharmacokinetics, and Antiretroviral Activity of Intravenous 9-[2-( R )-(Phosphonomethoxy)propyl]adenine, a Novel Anti-Human Immunodeficiency Virus (HIV) Therapy, in HIV-Infected AdultsAntimicrobial Agents and Chemotherapy, 1998
- Antiretroviral Efficacy and Pharmacokinetics of Oral Bis(isopropyloxycarbonyloxymethyl)9-(2-Phosphonylmethoxypropyl)adenine in MiceAntimicrobial Agents and Chemotherapy, 1998
- Drug absorption studies of prodrug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transportInternational Journal of Pharmaceutics, 1998
- Synthesis, in Vitro Biological Evaluation and Oral Bioavailability of 9-[2-(Phosphonomethoxy)Propyl]Adenine (PMPA) ProdrugsAntiviral Chemistry and Chemotherapy, 1997
- Evidence for a Polarized Efflux System in Caco-2 Cells Capable of Modulating Cyclosporine A TransportBiochemical and Biophysical Research Communications, 1993
- Segmental Differences in Drug Permeability, Esterase Activity and Ketone Reductase Activity in the Albino Rabbit IntestineJournal of Drug Targeting, 1993
- Enzymic hydrolysis of nicotinate esters: comparison between plasma and liver catalysisXenobiotica, 1992
- A Comparison of Oral and Rectal Absorption of L-Dopa Esters in Rats and MicePharmaceutical Research, 1990